Australia has recorded no new cervical cancer diagnoses among women under the age of 25 for the first time, marking a significant public health milestone in the country's push to eradicate the disease entirely, according to a report by the BBC.
The achievement is largely attributed to Australia's long-running human papillomavirus (HPV) vaccination program, which the country introduced in 2007 - one of the earliest national rollouts of the vaccine in the world. HPV is the primary cause of cervical cancer.
A decades-long effort
Australia began offering the HPV vaccine to girls through schools in 2007, and extended the program to boys in 2013. Combined with a national cervical screening program that shifted to more sensitive HPV-based testing in 2017, the country has steadily driven down diagnosis rates over the past two decades.
The goal Australia has set for itself is to reduce cervical cancer rates below four cases per 100,000 women - the threshold the World Health Organization defines as elimination. Australian health authorities have stated they believe that target is achievable within the coming years for the broader population.
Global implications
If Australia achieves full elimination, it would become the first country in the world to eradicate a cancer - a landmark that researchers and public health officials say could provide a blueprint for other nations.
However, experts caution that the zero-diagnosis figure among under-25s, while encouraging, reflects the cohort that benefited most directly from early vaccination efforts. Older age groups continue to face higher rates of diagnosis, meaning the overall elimination target has not yet been reached.
Cervical cancer remains a major global health issue. According to the World Health Organization, it is the fourth most common cancer in women worldwide, with the burden falling disproportionately on low- and middle-income countries where access to vaccines and screening remains limited.
Challenges ahead
Health officials note that sustaining high vaccination coverage is critical to maintaining progress. Gaps in vaccine uptake among certain communities, including some rural and Indigenous populations in Australia, remain a concern that authorities say must be addressed to achieve and sustain elimination across all groups.
The development has drawn attention from international health organizations, who are watching Australia's progress as a potential model for global cervical cancer elimination efforts promoted under the WHO's 90-70-90 strategy - a framework targeting vaccination, screening, and treatment rates needed to bring the disease under control worldwide.
